Company
Editas Medicine
Editas Medicine has 3 drugs tracked on RxWires: 3 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| EDIT-301 | Phase 1/2 | Transfusion Dependent Beta Thalassemia |
| EDIT-101 | Phase 1/2 | Leber Congenital Amaurosis 10 |
| Drug: EDIT-401 | Phase 1/2 | Heterozygous Familial Hypercholesterolemia (HeFH) |
Latest
- editas medicine filed 8-K
- editas medicine filed 8-K
- editas medicine filed 8-K
- editas medicine filed 8-K
- editas medicine filed 8-K
Follow Editas Medicine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.